|
Oct 15
|
Almirall completes EU regulatory procedure for antifungal Jublia
|
|
Oct 15
|
Almirall Announces Completion of Decentralized Regulatory Approval Procedure for Efinaconazole in Europe
|
|
Jul 25
|
Almirall And Two Additional Stocks Considered Below Estimated Market Value
|
|
Dec 21
|
Almirall Initiates First Phase I Clinical Study of ALM223, an Interleukin 2 Mutant Fusion Protein for Autoimmune Diseases
|